Cargando…

Potential Elucidation of a Novel CTL Epitope in HIV-1 Protease by the Protease Inhibitor Resistance Mutation L90M

The combination of host immune responses and use of antiretrovirals facilitate partial control of human immunodeficiency virus type 1 (HIV-1) infection and result in delayed progression to Acquired Immunodeficiency Syndrome (AIDS). Both treatment and host immunity impose selection pressures on the h...

Descripción completa

Detalles Bibliográficos
Autor principal:	Smidt, Werner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756051/ https://www.ncbi.nlm.nih.gov/pubmed/24015196 http://dx.doi.org/10.1371/journal.pone.0071888

Ejemplares similares

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
por: Kourjian, G, et al.
Publicado: (2012)

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
por: Babrzadeh, Farbod, et al.
Publicado: (2013)

Structural analyses of 2015-updated drug-resistant mutations in HIV-1 protease: an implication of protease inhibitor cross-resistance
por: Su, Chinh Tran-To, et al.
Publicado: (2016)

Deep Sequencing of Protease Inhibitor Resistant HIV Patient Isolates Reveals Patterns of Correlated Mutations in Gag and Protease
por: Flynn, William F., et al.
Publicado: (2015)

Sensing HIV Protease and Its Inhibitor Using “Helical Epitope”—Imprinted Polymers
por: Chou, Chien-Yu, et al.
Publicado: (2020)

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
por: Wiesmann, Frank, et al.
Publicado: (2011)

Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010)

Switching and emergence of CTL epitopes in HIV-1 infection
por: Han, Chungyong, et al.
Publicado: (2014)

Drug Resistance Mutations Alter Dynamics of Inhibitor-Bound HIV-1 Protease
por: Cai, Yufeng, et al.
Publicado: (2014)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
por: Lopes, J., et al.
Publicado: (2021)

Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process
por: Adamson, Catherine S.
Publicado: (2012)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
por: Fun, Axel, et al.
Publicado: (2011)

Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022)

Evaluation of novel Saquinavir analogs for resistance mutation compatibility and potential as an HIV-Protease inhibitor drug
por: Jayaswal, Amit, et al.
Publicado: (2014)

Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations
por: Rhee, Soo-Yon, et al.
Publicado: (2022)

The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts
por: Kaseke, Clarety, et al.
Publicado: (2021)

The role of mutations at codons 32, 47, 54, and 90 in HIV-1 protease flap dynamics
por: Chordia, Poorvi, et al.
Publicado: (2014)

Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
por: Obasa, Adetayo Emmanuel, et al.
Publicado: (2020)

Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
por: Zeminian, Luciana Bonome, et al.
Publicado: (2013)

Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors
por: Bastys, Tomas, et al.
Publicado: (2020)

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2014)

Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009)

HIV Gag and PR: partners in resistance to protease and maturation inhibitors
por: Nijhuis, Monique
Publicado: (2011)

CTL Escape Mediated by Proteasomal Destruction of an HIV-1 Cryptic Epitope
por: Cardinaud, Sylvain, et al.
Publicado: (2011)

Resistance Mutations and CTL Epitopes in Archived HIV-1 DNA of Patients on Antiviral Treatment: Toward a New Concept of Vaccine
por: Papuchon, Jennifer, et al.
Publicado: (2013)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
por: Su, Chinh Tran-To, et al.
Publicado: (2019)

Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy
por: Dunn, David T., et al.
Publicado: (2018)

Analysis of drug resistance in HIV protease
por: Pawar, Shrikant D., et al.
Publicado: (2018)

Evolution of drug resistance in HIV protease
por: Shah, Dhara, et al.
Publicado: (2020)

Impacts of drug resistance mutations on the structural asymmetry of the HIV-2 protease
por: Laville, Pierre, et al.
Publicado: (2020)

Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
por: Laville, Pierre, et al.
Publicado: (2021)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

The distribution of CTL epitopes in HIV-1 appears to be random, and similar to that of other proteomes
por: Schmid, Boris V, et al.
Publicado: (2009)

Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection
por: Shimizu, Akihisa, et al.
Publicado: (2013)

Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control
por: Caetano, Diogo Gama, et al.
Publicado: (2018)

Development of Elvitegravir Resistance and Linkage of Integrase Inhibitor Mutations with Protease and Reverse Transcriptase Resistance Mutations
por: Winters, Mark A., et al.
Publicado: (2012)

Description of the L76V Resistance Protease Mutation in HIV-1 B and “Non-B” Subtypes
por: Charpentier, Charlotte, et al.
Publicado: (2013)

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors
por: Okafor, Sunday N., et al.
Publicado: (2023)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors
por: Codoñer, Francisco M, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qut3godtu1iejis435f8sibou5